Uday Kumar, MD
Director of Strategy, Biodesign Program
Fellowship Director, Global Biodesign Programs
Consulting Associate Professor, Bioengineering,
Founder, President & CEO, Element Science, Inc.
Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist (EP) by training, is currently the Founder, President and CEO of Element Science, Inc., a venture-backed company funded by Third Rock Ventures and Google Ventures that is developing an innovative device for the treatment of sudden cardiac death. Prior to this, he was an Entrepreneur-in-Residence at Third Rock Ventures, where he focused on leading the development of new medical devices and technologies. Uday is also the Founder of iRhythm Technologies, Inc., a digital health company that develops cost-effective devices and systems for cardiac rhythm monitoring. He served as a Board member and Chief Medical Officer of iRhythm from founding through broad commercialization of its Zio® Patch cardiac monitoring device. Uday also Co-Founded and serves as a Board Member of Qurious.io, Inc., co-founded and served as a Board Member of Sympara Medical, Inc., and is a Board Member of G-Tech Medical, Inc.
Additionally, he currently serves as a Consulting Associate Professor of Bioengineering at Stanford University and is the Director of Strategy of Stanfordís Biodesign Program and the Fellowship Director of Stanfordís Global Biodesign Programs, programs that teach processes for medical innovation to solve unmet medical needs. Uday was a Biodesign fellow at Stanford, a cardiac EP and cardiology fellow at the University of California, San Francisco (UCSF), and internal medicine resident at the Columbia-Presbyterian Hospital of Columbia University. Prior to his training, Uday was Vice-President and Chief Medical Officer of Biomedical Modeling Inc., a start-up company that created rapid prototyping models from imaging data for use in numerous medical applications. Uday received his M.D. and B.A. (magna cum laude in Biochemistry) from Harvard University.